MedicaidPrior AuthMedium impact
KMAP BULLETIN: Preferred Drug List and Prior Authorization Updates
Kansas Medicaid (KanCare)·KS · Pharmacy, Gastroenterology, Cardiology +2 more·Pharmacy
Effective date
Aug 1, 2024
We identified it
Jun 21, 2026
Summary
Kansas Medicaid (KMAP) has removed several medications from their preferred drug list effective August 1, 2024, and added prior authorization requirements for specific adalimumab biosimilar versions. A grandfather process protects existing patients with 80% adherence on maintenance medications.
Action Required
Immediately: Billing team must verify prior authorization requirements for adalimumab-aacf (Idacio) and adalimumab-adbm (Cyltezo) unbranded versions for Kansas Medicaid patients. Update billing system to flag these medications. Providers should be notified that hydrocortisone (Ala-Scalp) lotion, ondansetron 16mg ODT, and sacubitril/valsartan sprinkle caps are no longer preferred and may require step therapy or alternative medications.